Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril vs Amlodipine for Endothelial Dysfunction in Pediatric Hemodialysis Patients
NCT07879560Phase 3Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Nov 2026
- Primary completion
- Oct 2027
01
Overview
Phase 3, randomised trial of ramipril in endothelial dysfunction and hypertension (HTN) (2 arms), sponsored by Ain Shams University. Primary endpoint: Serum asymmetric dimethylarginine level at 3 months. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ramipril
03
Conditions
endothelial dysfunctionhypertension (HTN)
Beyond the preview
Go deeper on NCT07879560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07879560.